News

After a slow 2024, the biotech shell company Concentra Biosciences is back, offering to buy four biotechs in the past month ...
Discover why some biotechs fail but survive with cash on hand, and how players like Concentra are trying to unlock trapped ...
BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the second ...
Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Inovio Pharmaceuticals today and set a price target of $5.00. The company’s shares closed yesterday at $1.49. El ...
Detailed price information for Skye Bioscience Inc (SKYE-Q) from The Globe and Mail including charting and trades.
Another Massachusetts biotech has reached the end of the road. | Another Massachusetts biotech has reached the end of the ...